ARTICLE | doi:10.20944/preprints202002.0151.v1
Online: 11 February 2020 (15:01:49 CET)
An improved method for Fluctuation Enhanced Sensing (FES) is introduced. We enhanced the old binary fingerprinting method, where the fingerprint bit values were ± 1, by introducing ternary fingerprints utilizing a reference odor. In the ternary method, the fingerprint bit values are -1, 0, and +1 where the 0 value stands for the situation where the slope of the spectrum is identical to that of the reference odor. The application of the reference odor spectrum makes the fingerprint relative to the reference. This feature increases the information entropy of the fingerprints. The method is briefly illustrated by sensing bacterial odor in cow manure isolates.
REVIEW | doi:10.20944/preprints201908.0018.v1
Subject: Earth Sciences, Geophysics Keywords: glacial isostatic adjustment; sea level change; fingerprints of past ice melting
Online: 2 August 2019 (08:45:05 CEST)
Along with density and mass variations of the oceans driven by global warming, Glacial Isostatic Adjustment (GIA) in response to the last deglaciation still contributes significantly to present-day sea-level change. Indeed, in order to reveal the impacts of climate change, long term observations at tide gauges and recent absolute altimetry data need to be decontaminated from the effects of GIA. This is now realized by means of global models constrained by the observed evolution of the paleo-shorelines since the Last Glacial Maximum, which account for the complex interactions between the solid Earth, the cryosphere and the oceans. In the recent literature, past and present-day effects of GIA are often expressed in terms of fingerprints describing the spatial variations of several geodetic quantities like crustal deformation, the harmonic components of the Earth's gravity field, relative and absolute sea level. However, since it is driven by the sluggish readjustment occurring within the viscous mantle, GIA shall taint the pattern of sea-level variability also during the forthcoming centuries. The shapes of the GIA fingerprints reflect inextricable deformational, gravitational, and rotational interactions occurring within the Earth system. Using up-to-date numerical modeling tools, our purpose is to revisit and to explore some of the physical and geometrical features of the fingerprints, their symmetries and intercorrelations, also illustrating how they stem from the fundamental equation that governs GIA, i.e., the Sea Level Equation.
DATA DESCRIPTOR | doi:10.20944/preprints202209.0323.v1
Subject: Mathematics & Computer Science, Information Technology & Data Management Keywords: COVID-19; Open-source dataset; Drug Repurposing; Database system; Web application devel-opment; software development; Drug fingerprints; Bulk upload
Online: 21 September 2022 (10:14:11 CEST)
Although various vaccines are now commercially available, they have not been able to stop the spread of COVID-19 infection completely. An excellent strategy to quickly get safe, effective, and affordable COVID-19 treatment is to repurpose drugs that are already approved for other diseases as adjuvants along with the ongoing vaccine regime. The process of developing an accurate and standardized drug repurposing dataset requires a considerable level of resources and expertise due to the commercial availability of an extensive array of drugs that could be potentially used to address the SARS-CoV-2 infection. To address this bottleneck, we created the CoviRx platform. CoviRx is a user-friendly interface that provides access to the data, which is manually curated for COVID-19 drug repurposing data. Through CoviRx, the data curated has been made open-source to help advance drug repurposing research. CoviRx also encourages users to submit their findings after thoroughly validating the data, followed by merging it by enforcing uniformity and integ-rity-preserving constraints. This article discusses the various features of CoviRx and its design principles. CoviRx has been designed so that its functionality is independent of the data it dis-plays. Thus, in the future, this platform can be extended to include any other disease X beyond COVID-19. CoviRx can be accessed at www.covirx.org.